183 related articles for article (PubMed ID: 2955562)
1. Isolation of bovine complement factor H.
Mhatre A; Aston WP
Vet Immunol Immunopathol; 1987 Apr; 14(4):357-75. PubMed ID: 2955562
[TBL] [Abstract][Full Text] [Related]
2. Isolation of the fifth component of the bovine complement system.
Aston WP; Mhatre A; Macrae J
Vet Immunol Immunopathol; 1990 Apr; 24(4):301-12. PubMed ID: 2140216
[TBL] [Abstract][Full Text] [Related]
3. Isolation and characterization of rabbit H of the alternative complement pathway.
Nakano Y; Tobe T; Matsuda T; Sakamoto T; Tomita M
J Biochem; 1984 May; 95(5):1469-75. PubMed ID: 6746616
[TBL] [Abstract][Full Text] [Related]
4. Preferential inactivation of the C5 convertase of the alternative complement pathway by factor I and membrane cofactor protein (MCP).
Seya T; Okada M; Matsumoto M; Hong KS; Kinoshita T; Atkinson JP
Mol Immunol; 1991 Oct; 28(10):1137-47. PubMed ID: 1833639
[TBL] [Abstract][Full Text] [Related]
5. Cell-surface regulation of the human alternative pathway of complement. Sheep but not rabbit erythrocytes express factor I-dependent cofactor activity.
Ezzell JL; Parker CJ
Scand J Immunol; 1992 Jul; 36(1):79-87. PubMed ID: 1535452
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane.
Fearon DT
Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5867-71. PubMed ID: 293688
[TBL] [Abstract][Full Text] [Related]
7. Residual hemolytic and proteolytic activity expressed by Bb after decay-dissociation of C3b,Bb.
Fishelson Z; Müller-Eberhard HJ
J Immunol; 1984 Mar; 132(3):1425-9. PubMed ID: 6229580
[TBL] [Abstract][Full Text] [Related]
8. A circulating inhibitor of fluid-phase amplification. C3 convertase formation in systemic lupus erythematosus.
Waldo FB; Forristal J; Beischel L; West CD
J Clin Invest; 1985 Jun; 75(6):1786-95. PubMed ID: 3159752
[TBL] [Abstract][Full Text] [Related]
9. Purification and functional analysis of the polymorphic variants of the C3b/C4b receptor (CR1) and comparison with H, C4b-binding protein (C4bp), and decay accelerating factor (DAF).
Seya T; Holers VM; Atkinson JP
J Immunol; 1985 Oct; 135(4):2661-7. PubMed ID: 3161944
[TBL] [Abstract][Full Text] [Related]
10. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
Sahu A; Isaacs SN; Soulika AM; Lambris JD
J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
[TBL] [Abstract][Full Text] [Related]
11. Isolation and characterization of the third component of bovine complement.
Menger M; Aston WP
Vet Immunol Immunopathol; 1985 Dec; 10(4):317-31. PubMed ID: 3832572
[TBL] [Abstract][Full Text] [Related]
12. gp 58/68, a parasite component that contributes to the escape of the trypomastigote form of T. cruzi from damage by the human alternative complement pathway.
Fischer E; Ouaissi MA; Velge P; Cornette J; Kazatchkine MD
Immunology; 1988 Oct; 65(2):299-303. PubMed ID: 2973433
[TBL] [Abstract][Full Text] [Related]
13. Isolation of human complement factors C3, C5 and H.
Lundwall A; Eggertsen G
J Immunol Methods; 1985 Jul; 81(1):147-60. PubMed ID: 3160789
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the alternative C3 convertase and classical C5 convertase of complement by group A streptococcal M protein.
Hong K; Kinoshita T; Takeda J; Kozono H; Pramoonjago P; Kim YU; Inoue K
Infect Immun; 1990 Aug; 58(8):2535-41. PubMed ID: 2142480
[TBL] [Abstract][Full Text] [Related]
15. The separation of functionally distinct forms of the third component of human complement (C3).
Parkes C; DiScipio RG; Kerr MA; Prohaska R
Biochem J; 1981 Mar; 193(3):963-70. PubMed ID: 6458280
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of classical C5 convertase in the complement system by factor H.
Ito S; Tamura N
Immunology; 1983 Dec; 50(4):631-5. PubMed ID: 6228516
[TBL] [Abstract][Full Text] [Related]
17. Initiation of the alternative pathway of complement: recognition of activators by bound C3b and assembly of the entire pathway from six isolated proteins.
Schreiber RD; Pangburn MK; Lesavre PH; Müller-Eberhard HJ
Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3948-52. PubMed ID: 279011
[TBL] [Abstract][Full Text] [Related]
18. Paroxysmal nocturnal hemoglobinuria: deficiency in factor H-like functions of the abnormal erythrocytes.
Pangburn MK; Schreiber RD; Trombold JS; Müller-Eberhard HJ
J Exp Med; 1983 Jun; 157(6):1971-80. PubMed ID: 6222136
[TBL] [Abstract][Full Text] [Related]
19. Isolation, characterization, and mechanism of action of rat beta 1H.
Daha MR; van Es LA
J Immunol; 1982 Apr; 128(4):1839-43. PubMed ID: 6460812
[TBL] [Abstract][Full Text] [Related]
20. A low molecular weight inhibitor of the alternative complement pathway. I. Its isolation from human urine and the reaction mechanism.
Nagaki K; Matsumoto M; Kitamura H
Immunology; 1980 Dec; 41(4):789-98. PubMed ID: 6450726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
